Literature DB >> 7899083

A transient three-plasmid expression system for the production of high titer retroviral vectors.

Y Soneoka1, P M Cannon, E E Ramsdale, J C Griffiths, G Romano, S M Kingsman, A J Kingsman.   

Abstract

We have constructed a series of MLV-based retroviral vectors and packaging components expressed from the CMV promoter and carried on plasmids containing SV40 origins of replication. These two features greatly enhanced retroviral gene expression when introduced into cell lines carrying the SV40 large T antigen. The two packaging components, gag-pol and env, were placed on separate plasmids to reduce helper virus formation. Using a highly transfectable human cell line and sodium butyrate to further increase expression of each component, we achieved helper-free viral stocks of approximately 10(7) infectious units/ml by 48 h after transient co-transfection with the three plasmid components. This system can be used both for the generation of high titer retroviral stocks for transduction and for the rapid screening of a large number of MLV gag-pol or env mutants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7899083      PMCID: PMC306730          DOI: 10.1093/nar/23.4.628

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.

Authors:  J Price; D Turner; C Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  Creation of a processed pseudogene by retroviral infection.

Authors:  M Linial
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

4.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Powerful and versatile enhancer-promoter unit for mammalian expression vectors.

Authors:  M K Foecking; H Hofstetter
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

8.  Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activation sequence but does not require TATA sequences.

Authors:  J E Ogden; C Stanway; S Kim; J Mellor; A J Kingsman; S M Kingsman
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  Amphotropic retrovirus vector system for human cell gene transfer.

Authors:  J Sorge; D Wright; V D Erdman; A E Cutting
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.

Authors:  J R Sanes; J L Rubenstein; J F Nicolas
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  286 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  A model for studying megakaryocyte development and biology.

Authors:  G J Murphy; A D Leavitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Authors:  S S Case; M A Price; C T Jordan; X J Yu; L Wang; G Bauer; D L Haas; D Xu; R Stripecke; L Naldini; D B Kohn; G M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Identification of the block in targeted retroviral-mediated gene transfer.

Authors:  Y Zhao; L Zhu; S Lee; L Li; E Chang; N W Soong; D Douer; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Use of a transient assay for studying the genetic determinants of Fv1 restriction.

Authors:  M Bock; K N Bishop; G Towers; J P Stoye
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Identification of the regions of Fv1 necessary for murine leukemia virus restriction.

Authors:  K N Bishop; M Bock; G Towers; J P Stoye
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging.

Authors:  S S Yu; J M Kim; S Kim
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses.

Authors:  David L Wensel; Weihua Li; James M Cunningham
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.

Authors:  Marcus Picard-Maureau; Gergely Jarmy; Angelika Berg; Axel Rethwilm; Dirk Lindemann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.